A pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a pilot …

P Damronglerd, C Sukasem… - Pharmacogenomics …, 2015 - Taylor & Francis
Objective We aimed at comparing clinical/immunological outcomes in human
immunodeficiency virus (HIV)-infected patients who were treated with CYP2B6-guided and …
被引用次数：10 相关文章

Apharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HI V-infected Thai patients: A pilot …

P Damronglerd, C Sukasem… - …, 2015 - mahidol.elsevierpure.com
Objective: We aimed at comparing clinical/immunological outcomes in human
immunodeficiency virus (HIV)-infected patients who were treated with CYP2B6-guided and …

A pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a pilot …

P Damronglerd, C Sukasem… - Pharmacogenomics …, 2015 - europepmc.org
Objective We aimed at comparing clinical/immunological outcomes in human
immunodeficiency virus (HIV)-infected patients who were treated with CYP2B6-guided and …

A pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a pilot …

P Damronglerd, C Sukasem… - Pharmacogenomics …, 2015 - dovepress.com
Objective: We aimed at comparing clinical/immunological outcomes in human
immunodeficiency virus (HIV)-infected patients who were treated with CYP2B6-guided and …
[PDF] semanticscholar.org

[PDF][PDF] a pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among hiV-infected Thai patients: a …

P Damronglerd, W Thipmontree - Pharmacogenomics …, 2015 - pdfs.semanticscholar.org
Objective: We aimed at comparing clinical/immunological outcomes in human
immunodeficiency virus (HIV)-infected patients who were treated with CYP2B6-guided and …

A pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a pilot …

P Damronglerd, C Sukasem… - …, 2015 - pubmed.ncbi.nlm.nih.gov
Objective We aimed at comparing clinical/immunological outcomes in human
immunodeficiency virus (HIV)-infected patients who were treated with CYP2B6-guided and …
[HTML] nih.gov

[HTML][HTML] A pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a …

P Damronglerd, C Sukasem… - Pharmacogenomics …, 2015 - ncbi.nlm.nih.gov
Objective We aimed at comparing clinical/immunological outcomes in human
immunodeficiency virus (HIV)-infected patients who were treated with CYP2B6-guided and …
[PDF] academia.edu

[PDF][PDF] a pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among hiV-infected Thai patients: a …

P Damronglerd, W Thipmontree - … and Personalized Medicine, 2015 - academia.edu
Objective: We aimed at comparing clinical/immunological outcomes in human
immunodeficiency virus (HIV)-infected patients who were treated with CYP2B6-guided and …

A pharmacogenomic prospective randomized controlled trial of CYP2B6polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a pilot …

P Damronglerd, C Sukasem… - Pharmacogenomics …, 2015 - search.proquest.com
Objective: We aimed at comparing clinical/immunological outcomes in human
immunodeficiency virus (HIV)-infected patients who were treated with CYP2B6-guided and …
[PDF] psu.edu

[PDF][PDF] a pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among hiV-infected Thai patients: a …

P Damronglerd, W Thipmontree - Pharmacogenomics and Personalized …, 2015 - Citeseer
Objective: We aimed at comparing clinical/immunological outcomes in human
immunodeficiency virus (HIV)-infected patients who were treated with CYP2B6-guided and …